[1]
2025. Potential Collaborative Markers for Nasopharyngeal Carcinoma Diagnosis and Therapy: AGR2 and AKR1B10. Clinical Medicine and Pharmacology. 2, 1 (May 2025). DOI:https://doi.org/10.70731/rek12e38.